Amylyx Pharmaceuticals

AMLX

NASDAQHealth Care

Income Statement

Total Revenue$-607K

Gross Profit$-8.83M

Operating Income$0

EBITDA$0

EBIT$-171.35M

Pre-tax Income$-219.49M

Net Income$-218.86M

Cash Equivalent$204.07M

Total Debt$0

Book Value$164.77

Book Value Per Share2.40

Return on Equity (ROE)-183.14%

Return on Assets (ROA)-155.83%

Return on Invested Capital (ROI)-183.14%

Net Profit Margin-345.36%

Current Ratio6.67

Quick Ratio6.23

Long-Term Debt / Equity0.00